Skip to main content
. 2021 Aug 2;8(2):e001707. doi: 10.1136/openhrt-2021-001707

Figure 3.

Figure 3

Forest plot showing pooled risk estimates according to outcomes of interest in subgroups of patients with acute coronary syndrome (red) (n=13 466) and chronic coronary syndrome (black) (n=4281) comparing short duration of dual-antiplatelet therapy (≤6 months) and long duration (12 months); (DAPT, dual antiplatelet therapy).